Romlusevimab

• Target:

  SARS-CoV

• Related Pathways:

  Microbiology/Virology

• Purity:

  1

• Bioactivity:

  Romlusevimab (BRII-198) is a recombinant antibody targeting the spike protein of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), with antiviral activity, used for research on COVID-19 infection.

• Shipping Conditions:

  Cool pack

• Storage Temperature:

  -20°C

• CAS Number:

  2509447-08-7